NALCN pathogenic variants have been associated to Neuroaxonal Dystrophy (INAD) patients, as well as to patients with severe hypotonia, speech impairment, cognitive delay, epilepsy, and mental disability [48]. The gene discussed is NALCN; the disease is Global developmental delay.